See All Slides - tctmd.com

Slides

Presentation ESC 2015

Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX Treatment Duration Program

Presenter: Marco Valgimigli

September 01, 2015

Presentation ESC 2015

Long-term Dual Antiplatelet Therapy for 2° Prevention of Cardiovascular Events in Patients with Previous Myocardial Infarction

Presenter: Jacob A. Udell

August 31, 2015

Presentation ESC 2015

12 vs 48 months of dual antiplatelet therapy after drug-eluting stent placement: The OPTIDUAL Randomized Trial

Presenter: G?rard Helft

August 31, 2015

Presentation ESC 2015

CIRCUS Study: Does Cyclosporine Improve Clinical Outcome is ST-Elevation Myocardial Infarction Patients?

Presenter: Michael Ovize

August 30, 2015

Presentation ESC 2015

Aldosterone Lethal Effects Blockade in Acute Myocardial Infarction Treated With or Without Reperfusion to Improve Outcome and Survival at Six Months Follow-Up

Presenter: Gilles Montalescot

August 30, 2015

Presentation ESC 2015

Peri-infarct Zone Pacing to Prevent Adverse Left Ventricular Remodeling in Patients with Large Myocardial Infarction: Results from the PRomPT Trial

Presenter: Gregg W. Stone

August 30, 2015

Presentation

Incidence, Predictors, and Impact of Postdischarge Bleeding After PCI

Presenter: P. G?n?reux

August 28, 2015

Presentation

Stent Fracture After SES Implantation

Presenter: M. Ohya

August 28, 2015

Presentation

Effectiveness of Cardiac Rehabilitation Among Older Patients after Acute MI

Presenter: Jacob A. Doll

August 27, 2015

Presentation

Baseline Characteristics and Prognostic Implications of Preexisting and New-Onset A-fib After TAVR

Presenter: R. Chopard

August 27, 2015

Advertisement

Slides

Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX Treatment Duration Program

Long-term Dual Antiplatelet Therapy for 2° Prevention of Cardiovascular Events in Patients with Previous Myocardial Infarction

12 vs 48 months of dual antiplatelet therapy after drug-eluting stent placement: The OPTIDUAL Randomized Trial

CIRCUS Study: Does Cyclosporine Improve Clinical Outcome is ST-Elevation Myocardial Infarction Patients?

Aldosterone Lethal Effects Blockade in Acute Myocardial Infarction Treated With or Without Reperfusion to Improve Outcome and Survival at Six Months Follow-Up

Peri-infarct Zone Pacing to Prevent Adverse Left Ventricular Remodeling in Patients with Large Myocardial Infarction: Results from the PRomPT Trial

Incidence, Predictors, and Impact of Postdischarge Bleeding After PCI

Stent Fracture After SES Implantation

Effectiveness of Cardiac Rehabilitation Among Older Patients after Acute MI

Baseline Characteristics and Prognostic Implications of Preexisting and New-Onset A-fib After TAVR

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content